Huang Bai
Phellodendron chinense C.K.Schneid.
Also known as: Amur Cork-Tree Bark(English) 黄柏(Chinese)
Huang Pai
Updated October 23, 2026 · Not yet clinically reviewed
Safety at a glance
6 recorded drug interactions, 2 major or contraindicated
Contraindications or side effects are listed
No toxicity grade is recorded. Most herbs in the catalogue carry none.
Traditional Chinese Medicine
- Category
- clearing heat
- Temperature
- Cold
- Taste
- Bitter
- Channels
- Kidney,Bladder,Large Intestine
Functions
Drains Damp-Heat especially from the Lower Jiao; Drains Kidney Fire (False Heat, Deficiency Heat); Drains Fire and relieves Fire toxicity
Traditional uses
Huang Bai is the dried bark of Phellodendron chinense (or P. amurense, Rutaceae), a classic bitter, cold heat-clearing/Damp-Heat-drying herb entering the Kidney, Bladder and Large Intestine channels. Its hallmark is draining Damp-Heat from the Lower Jiao: thick yellow vaginal discharge, damp genital itching and sores, Damp-Heat diarrhea and dysentery, turbid painful urination, and hot, swollen, weak knees and legs (as in Er Miao San with Cang Zhu). It drains Kidney Fire and Deficiency-Heat with steaming bones, night sweats and nocturnal emission, classically paired with Zhi Mu and Yin tonics in Zhi Bai Di Huang Wan.
It also drains Fire and relieves Fire-toxicity in hot sores, abscesses and eczema, applied internally or topically. Being cold and bitter, it is used cautiously in Spleen/Stomach deficiency and Cold patterns.
Western herbalism
Properties: bitter, antimicrobial, anti-inflammatory
Pharmacological effects
- Antimicrobial: Antibacterial like Huang Lian, stronger in vivo than in vitro; decoction/extract inhibit many bacteria, especially Shigella species, and streptomycin/PAS/isoniazid-resistant M. tuberculosis; antifungal against skin fungi.
- Hypotensive: Alkaloid fraction, fluid extract and bark lowered blood pressure in cats and hypertensive rats; phellodendrine and palmatine (10 mg/kg i.v.) hypotensive via ganglionic blockade, vasomotor centre inhibition and sympathetic antagonism.
- Cellular immunosuppressive: Magnoflorine and phellodendrine (5-20 mg/kg i.p.) inhibited graft-versus-host and delayed-type hypersensitivity induction in mice without affecting antibody production.
- Antinephritic: Oral phellodendrine 25-100 mg/kg prevented proteinuria and crescent formation in rat anti-GBM nephritis, reducing glomerular macrophages and cytotoxic T cells.
- Antiulcerative: Berberine-free fraction inhibited ethanol, aspirin, pylorus-ligation and stress ulcers in rodents and reduced gastric acid secretion (s.c. or intraduodenal).
- Inflammation and pituitary-adrenal: Bark reduces local inflammation; palmatine caused thymic atrophy in young mice and lowered adrenal vitamin C in rats (abolished by hypophysectomy).
- Other effects: Bark, limonin and obakunone shortened alpha-chloralose/urethane sleep in mice; strong antifeedant activity against termites.
Source: Zhu YP. Chinese Materia Medica: Chemistry, Pharmacology and Applications. Harwood Academic, 1998, p. 141.
Formulas using this herb
86 of 86 formulas
- Ba Xian Xiao Yao San · 6.00000g
- Bai Mao Gen Tang 白茅根汤
- Bai Tou Weng Jia Gan Cao E Jiao Tang 白头翁加甘草阿胶汤 · 12.00000g
- Bai Tou Weng Tang 白头翁汤 · 12.00000g · deputy
- Bao Yin Jian · 4.50000g
- Bao Zhen Tang · 6.00000g
- Bi Xie Shen Shi Tang · 6.00000g
- Cheng Shi Bi Xie Fen Qing Yin · 1.50000g
- Da Bu Yin Wan 大补阴丸 · 120.00000g · deputy
- Da Huang Lian Bai Tang 大黄连柏汤
- Da Qing Tang 大青汤
- Dan Huang Si Ni San 丹黄四逆散 · 12.00000g
- Dang Gui Liu Huang Tang 当归六黄汤 · 12.00000g · deputy
- Dang Gui Long Hui Wan 当归龙荟丸 · 30.00000g
- Dao Chi Cheng Qi Tang 导赤承气汤 · 6.00000g
- Er Miao San 二妙散 · 15.00000g · chief
- Er Xian Tang 二仙汤 · 6.00000g · assistant
- Fu Fang Ba Zheng San 复方八正散
- Gou Chong Wan · 10.00000g
- Gu Jing Wan 固经丸 · 6.00000g · deputy
- He Che Da Zao Wan 大造丸 · 45.00000g
- Hu Qian Wan 虎潜丸 · chief
- Huan Yin Jiu Ku Tang · 4.50000g
- Huang Lian Gao · 6.00000g
- Huang Lian Jie Du Tang 黄连解毒汤 · 6.00000g · assistant
- Huang Lian Shang Qing Wan 黄连上清丸 · 240.00000g
- Huo Xue Tong Lin Tang 活血通淋汤
- Jia Wei Bai Tou Weng Tang 加味白头翁汤 · 6.00000g
- Jia Wei Er Miao Wan 加味二妙丸 · 15.00000g
- Jin Huang San 金黄散 / 金黄膏 · 2500.00000g
- Ku Shen Tang 苦参汤 · 30.00000g
- Li Shi Ban Xia Bai Zhu Tian Ma Tang · 3.00000g
- Lian Mei An Hui Tang 连梅安蛔汤 · 2.40000g
- Long Dan Jie Du Tang 龙胆解毒汤
- Lu Pao San 绿袍散 · 120.00000g
- Mu Xiang Bin Lang Wan 木香槟榔丸 · 30.00000g · assistant
- Niu Huang Shang Qing Wan 牛黄上清丸 · 15.00000g
- Qi Wu Jiang Xia Tang 七物降下汤 · 2.00000g
- Qing Dai San 青黛散 · 60.00000g
- Qing Jing San 清经散 · 1.50000g
- Qing Jing Zhi Xue Tang · 12.00000g
- Qing Re Liang Xue Tang 清热凉血汤
- Qing Re Tong Lin Tang 清热通淋汤
- Qing Re Zhi Beng Tang · 9.00000g
- Qu Feng Zhi Bao Dan 祛风至宝丹 · 15.00000g
- San Cai Feng Sui Dan · 90.00000g
- San Huang Shi Gao Tang 三黄石膏汤 · 3.00000g
- San Huang Xi Ji
- San Miao Wan 三妙丸 · 12.00000g
- San Zhong Kui Jian Tang 散肿溃坚汤 · 15.00000g
- Sang Zhi Shi Gao Zhi Mu Tang 桑枝石膏知母汤
- Shang Zhong Xia Tong Yong Tong Feng Wan 上中下通用痛风丸 · 21.00000g
- Shao Yao Hou Po Tang 芍药厚朴汤
- Shen Xian Huo Ming Tang · 4.50000g
- Shi Gao Tang 石膏汤 · 6.00000g · assistant
- Shi Wei Di Huang Wan 十味地黄丸
- Shu Feng Huo Xue Tang 疏风活血汤 · 3.00000g
- Shuang Bai San · 500.00000g
- Si Huang Gao · 30.00000g
- Si Huang San · 30.00000g
- Si Miao Wan 四妙丸 · 12.00000g
- Su Mu Jian · 9.00000g
- Tiao Yuan Shen Qi Wan · 15.00000g
- Tong Feng Wan 痛风丸
- Tong Guan Zi Shen Wan 通关滋肾丸 · 30.00000g · chief
- Wen Qing Yin 温清饮 · 4.50000g
- Wu Ling Tong Guan Tang 五苓通关汤 · 3.00000g
- Wu Mei Wan 乌梅丸 · 6.00000g · deputy
- Wu Wei Tang · 1.50000g
- Xi Tong Fang Er Hao 膝痛方二號
- Xie Gan Tang 泻肝汤 · 15.00000g
- Yi Huang Tang 易黄汤 · 6.00000g · assistant
- Yi Qi Cong Ming Tang 益气聪明汤 · 3.00000g
- Yi Yang Jiu Lian San · 1.50000g
- Yu Dai Wan 愈帶丸 · 12.00000g
- Yue Shi San 月石散 · 24.00000g
- Zhi Bai Di Huang Wan 知柏地黄丸 · 6.00000g · deputy
- Zhi Dai Fang · 15.00000g
- Zhi Shang Yi Fang · 10.00000g
- Zhi Zhuo Gu Ben Wan 治浊固本丸
- Zhi Zi Bai Pi Tang 栀子柏皮汤 · 6.00000g
- Zhi Zi Jiang Huo Tang 栀子降火汤
- Zhong Man Fen Xiao Tang 中满分消汤 · 15.00000g
- Zi Shen Tong Er Tang 滋肾通耳汤
- Zi Yin Jiang Huo Tang 滋阴降火汤 · 1.50000g · assistant
- Zi Yin Qing Re Tang 滋阴清热汤
Botanical
Huang Bai is the dried inner bark of Phellodendron chinense C.K.Schneid. or Phellodendron amurense Rupr. (Rutaceae), commonly called Chinese or Amur cork tree. The parent tree is a medium to large deciduous tree 10-25 m tall, with a broad rounded crown and a distinctive thick, deeply furrowed, soft and corky outer bark whose inner layer is brilliant yellow due to high berberine content. Opposite, odd-pinnately compound leaves bear 5-13 ovate-lanceolate leaflets, 5-10 cm long, finely toothed, and emit a pungent citrus-like odor when crushed. Dioecious panicles of small greenish-yellow flowers yield clusters of pea-sized black drupes that persist into winter. The harvested inner bark is intensely bitter and yellow, and supplies the major TCM herb for clearing damp-heat from the lower jiao, used in jaundice, leukorrhea, dysentery, and inflammatory skin conditions. Phellodendron amurense is now listed as endangered in parts of its range.
- Family
- Rutaceae
- Pharmaceutical name
- Cortex Phellodendri
- Parts used
- bark
- Plant type
- tree
- Native region
- Guizhou, Hubei, Jiangxi, Sichuan, Yunnan, Zhejiang
Constituents
Berberine
Protoberberine isoquinoline alkaloid · the Chinese Pharmacopoeia standard for Phellodendri Chinensis Cortex is not less than 3.0 percent berberine hydrochloride in the dried bark
The dominant alkaloid of this species and the compound that carries almost all of the documented pharmacology and essentially all of the documented human drug interactions of the drug. Oral absorption is very poor, so systemic effects at herbal doses are modest while gut-level antimicrobial and transporter effects are not.
Phellodendrine
Quaternary tetrahydroprotoberberine alkaloid · the Chinese Pharmacopoeia standard for Phellodendri Chinensis Cortex is not less than 0.34 percent phellodendrine hydrochloride
Genus-specific, and for that reason it is the second pharmacopoeial assay marker for the Chinese species. Because berberine also occurs in Coptis, Berberis and Mahonia, phellodendrine rather than berberine is what confirms that a sample is genuinely Phellodendron.
Palmatine
Protoberberine isoquinoline alkaloid
A close structural analogue of berberine present as a secondary alkaloid. It is not the assay marker for the Chinese species, but it is the pharmacopoeial marker for the Amur species, which is one of the practical ways the two barks are told apart.
Jatrorrhizine
Protoberberine isoquinoline alkaloid
A demethylated protoberberine that occurs alongside berberine and palmatine and contributes to the total quaternary alkaloid load of the bark.
Magnoflorine
Quaternary aporphine alkaloid
Present in both Phellodendron species but proportionally much more prominent in the Amur species, where it has been proposed as a quality marker. It has been reported to increase tissue uptake of berberine when the two are given together.
Obacunone
Limonoid (degraded triterpenoid)
One of the bitter limonoids of the bark, along with obaculactone (limonin). These non-alkaloid constituents are part of what distinguishes Phellodendron bark chemically from the other berberine-bearing crude drugs.
Drug interactions
Ciclosporin (cyclosporin A)
Major · Ciclosporin blood levels rise substantially, risking nephrotoxicity and other concentration-dependent toxicity · Evidence level: Established
This is one of the few herb-drug interactions in this area documented directly in patients rather than inferred. In a controlled study in renal transplant recipients, berberine 0.2 g three times daily raised ciclosporin trough concentrations by 88.9 percent and the concentration/dose ratio by 98.4 percent against baseline; in the pharmacokinetic substudy, twelve days of the same berberine regimen increased ciclosporin AUC by 34.5 percent and cut apparent oral clearance by 40.4 percent. The authors attributed it to inhibition of CYP3A4 in liver and small intestine, and berberine also inhibits intestinal P-glycoprotein, which carries ciclosporin. Berberine is the principal alkaloid of this bark, so the interaction should be assumed for the crude drug.
Clinical note: Do not add Huang Bai to a stable transplant or autoimmune regimen containing ciclosporin without arranging trough monitoring first, and treat any change in the herbal prescription as a reason to re-check levels.
CYP3A4 substrates (e.g. midazolam, tacrolimus, simvastatin)
Moderate · Substrate exposure increases; effect and toxicity of the co-administered drug may be amplified · Evidence level: Probable
In healthy volunteers given berberine 300 mg three times daily for two weeks against probe substrates, berberine inhibited CYP3A4 activity as well as CYP2D6 and CYP2C9. The rat work of Qiu and colleagues, which showed increased exposure to CYP3A and P-glycoprotein substrates after berberine, points the same way. The size of the effect from a herbal decoction of the bark has not been measured directly, so this is graded below the ciclosporin evidence.
Clinical note: Treat as a real interaction for narrow-therapeutic-index CYP3A4 substrates; for wide-margin drugs, note it and monitor for exaggerated effect rather than avoiding the herb.
CYP2D6 and CYP2C9 substrates (e.g. dextromethorphan, metoprolol, losartan)
Moderate · Reduced clearance of the substrate, with exaggerated or prolonged drug effect · Evidence level: Probable
The same human repeated-dose study found that berberine inhibited CYP2D6 and CYP2C9 in addition to CYP3A4. CYP2D6 is polymorphic, so the practical consequence is largest in extensive metabolisers taking a drug whose activity depends on that route.
Clinical note: Ask specifically about beta-blockers, antidepressants, antipsychotics and sartans before prescribing this herb long term, and review for signs of over-treatment rather than assuming the herb is inert.
P-glycoprotein substrates (e.g. digoxin)
Moderate · Higher plasma concentration of the substrate; for digoxin, a shift toward toxic levels · Evidence level: Possible
Berberine inhibits intestinal P-glycoprotein. In rats, gavage with berberine 100 mg/kg for two weeks raised the AUC of digoxin by about 69 percent. This has not been reproduced in humans, and it is a rat dose, so the human relevance is inferred rather than measured.
Clinical note: For digoxin specifically, the margin is small enough that the possibility is worth a level check if the herb is used for more than a few days.
Neonatal use and any drug or condition raising unconjugated bilirubin
Major · Free bilirubin rises and can cross the blood-brain barrier; kernicterus is the feared outcome in the newborn · Evidence level: Probable
Berberine displaces bilirubin from serum albumin. In vitro it was roughly tenfold more potent as a displacer than phenylbutazone and about a hundredfold more potent than papaverine, and chronic dosing in rats significantly reduced bilirubin protein binding with a persistent rise in unbound and total serum bilirubin. This is a genuine mechanistic contraindication, not a precaution: Singapore has restricted berberine-containing Coptis and Phellodendron since 1978 on exactly this basis. The published clinical evidence linking the herbs themselves to kernicterus is contested, but the displacement chemistry is not.
Clinical note: Do not give this herb to neonates, to jaundiced infants, or to a woman in the peripartum period where the alkaloid may reach the newborn through the placenta or breast milk. Say so explicitly rather than listing it as a caution.
Glucose-6-phosphate dehydrogenase deficiency and oxidant drugs in haemolysis-prone patients
Moderate · Possible haemolysis or worsening of an existing haemolytic anaemia · Evidence level: Possible
The historical allegation is that berberine-containing Coptis and Phellodendron aggravate haemolysis in G6PD-deficient patients. A clinical re-examination of the question in patients with chronic haematological disease found the evidence for berberine-induced haemolysis to be weaker than the ban implies, but recommended bilirubin and haemoglobin monitoring where an underlying haemolytic disease exists. So the risk is real enough to monitor and not strong enough to prohibit in adults.
Clinical note: In a patient with known G6PD deficiency, thalassaemia or another chronic haemolytic disorder, check haemoglobin and bilirubin before and during a course rather than refusing the herb outright.
Dosage
| Form | Amount | Frequency | Notes |
|---|---|---|---|
| decoction | 3–12 g | Daily | 中国药典 2020 monograph 【黄柏】【用法与用量】3~12g。外用适量。 【性味与归经】苦,寒。归肾、膀胱经。 — Matched to ChP by romanised drug name (pinyin 'Huang Bai' → 黄柏); the romanisation is unique across all 649 ChP monographs, and the match was cross-checked against this record's own TCM temperature. Quoted verbatim. |
Dui yao: classical pairings
Huang Bai + Cang Zhu苍术
Together they clear heat and dry damp in the lower burner, treating damp-heat descending to the legs.
Classic indication: hot, swollen, painful legs and knees, or damp-heat leukorrhea.
Core pair of a classical formula — Er Miao San, Dan Xi Xin Fa (Zhu Danxi)
Huang Bai + Zhi Mu知母
Together they drain Kidney fire and nourish yin, treating steaming bone fever, night sweats and deficiency-fire signs.
The pair is the core addition in Zhi Bai Di Huang Wan and appears in Da Bu Yin Wan.
Named pairing — Lu Jingshan, Shi Jinmo Dui Yao
Huang Bai + Zhi Zi栀子
Clearing heat through the three burners is combined with clearing damp-heat from the lower burner, treating damp-heat jaundice with heat predominant.
Core pair of a classical formula — Zhi Zi Bai Pi Tang, Shang Han Lun (Zhang Zhongjing)
Evidence
Study design on record, not certainty of outcome.
- Randomized controlled trial
- 2
- Other clinical trial
- 1
- In vitro / animal
- 4
Effects of berberine on the blood concentration of cyclosporin A in renal transplanted recipients: clinical and pharmacokinetic study
Wu, Xiaochun; Li, Qing; Xin, Huawen; Yu, Airong; Zhong, Mingyuan · European Journal of Clinical Pharmacology · 2005 · RCT
Randomized controlled trial · Verified
A randomised controlled trial in renal transplant recipients taking ciclosporin, with berberine 0.2 g three times daily for three months, plus a pharmacokinetic substudy in six patients. Ciclosporin trough concentrations rose 88.9 percent and the concentration/dose ratio 98.4 percent versus baseline; twelve days of berberine raised ciclosporin AUC by 34.5 percent and reduced apparent oral clearance by 40.4 percent. The authors attributed the effect to CYP3A4 inhibition in liver and gut.
Repeated administration of berberine inhibits cytochromes P450 in humans
Guo, Ying; Chen, Yao; Tan, Zhi-rong; Klaassen, Curtis D.; Zhou, Hong-hao · European Journal of Clinical Pharmacology · 2012 · cohort
Randomized controlled trial · Verified
Healthy volunteers took berberine 300 mg three times daily for two weeks and were phenotyped with probe substrates before and after. Berberine inhibited CYP2D6, CYP2C9 and CYP3A4 activity. This is the main human evidence that the interaction risk from berberine-bearing herbs is not confined to ciclosporin.
Berberine‐induced Haemolysis Revisited: Safety of Rhizoma coptidis and Cortex phellodendri in Chronic Haematological Diseases
Linn, Yeh-ching; Lu, Jiahui; Lim, Lay-cheng; Sun, Huili; Sun, Jue; Zhou, Yongming; Ng, Han-seong · Phytotherapy Research · 2012 · cohort
Other clinical trial · Verified
A clinical and literature re-examination of the haemolysis allegation that led Singapore to ban Coptis and Phellodendron in 1978. The authors found the evidence for berberine-induced haemolysis conflicting rather than conclusive, and concluded that the two herbs can be used in patients with chronic haematological disease provided haemoglobin and bilirubin are monitored. It does not overturn the separate neonatal bilirubin-displacement concern.
Displacement of Bilirubin from Albumin by Berberine
Chan, Eli · Biology of the Neonate · 1993 · animal
In vitro / animal · Not yet verified
Berberine was about tenfold more potent than phenylbutazone and about a hundredfold more potent than papaverine at displacing bilirubin from albumin in vitro. Chronic berberine administration in rats significantly lowered mean bilirubin serum protein binding and produced a persistent rise in steady-state unbound and total bilirubin. This is the mechanistic basis for the kernicterus contraindication in neonates.
Evaluation of raw and processed Phellodendri Chinensis Cortex using the quality marker analysis strategy by UHPLC-Q-Orbitrap MS and multivariate statistical analysis
Wang, Wang; Shi, Xuqin; Zhu, Guoxue · Frontiers in Chemistry · 2023 · in vitro
In vitro / animal · Not yet verified
Raw, salt-processed and charred Phellodendri Chinensis Cortex, the three forms the Chinese Pharmacopoeia recognises, were profiled by UHPLC-Q-Orbitrap MS and separated by multivariate analysis. The three processed forms are chemically distinguishable, which is the analytical justification for dispensing them separately: raw and salt-processed material is used for damp-heat diarrhoea and jaundice, and the charred form for bleeding.
The Effects of Salt-Water Processing of Phellodendri Chinensis Cortex on the Enhancement of Kidney Absorption of the Main Alkaloids
Zhang, Fan; Li, Li; Zhao, Jia-hui; Ge, Xiu-tong; Gao, Hui; Jia, Tian-zhu · Natural Product Communications · 2022 · animal
In vitro / animal · Not yet verified
Salt-water processing, the preparation traditionally said to direct the herb to the Kidney, increased renal uptake of the main alkaloids relative to the raw bark. It gives a pharmacokinetic reading of the classical claim that salt-processed Huang Bai is the form for draining Kidney fire.
A strategy for evaluating the impact of processing of Chinese meteria medica on meridian tropism: the influence of salt-water processing of phellodendri chinensis cortex on renal transport proteins
Chen, Yang; Zhang, Fan; Ren, Wenjing; Zhou, Yue; Jiang, Shiru; Zhang, Shuo; Xu, Gui; Ge, Xiutong; Gao, Hui · Frontiers in Pharmacology · 2025 · animal
In vitro / animal · Not yet verified
Compared with the raw bark, salt-processed Phellodendri Chinensis Cortex increased the uptake capacity and expression of the renal organic cation transporter OCT2 and decreased the efflux capacity and expression of P-glycoprotein and MRP2. The authors read this as a transporter-level mechanism for the increased renal targeting of the salt-processed drug.
Safety
Contraindications
Its use is prohibited in patients with deficiency-cold of the spleen and stomach due to its bitter-cold property.
Source: Xi S, Gong Y. Essentials of Chinese Materia Medica and Medical Formulas. Academic Press/Elsevier, 2017, pp. 46–50.
Side effects
- No side effects reported except one case of skin allergy after oral use.
Source: Zhu YP. Chinese Materia Medica: Chemistry, Pharmacology and Applications. Harwood Academic, 1998, p. 141.
Cultural and historical
Shen Nong Ben Cao Jing · Han dynasty
Ge Zhi Yu Lun (Zhu Zhen-heng / Zhu Dan-xi) · Yuan dynasty
Ben Cao Gang Mu · Ming dynasty
References
- Sun, Yue; Lenon, George Binh; Yang, Angela Wei Hong. Phellodendri Cortex: A Phytochemical, Pharmacological, and Pharmacokinetic Review. Evidence-Based Complementary and Alternative Medicine. 2019 doi:10.1155/2019/7621929
- Qiu, W.; Jiang, X. H.; Liu, C. X.; Ju, Y.; Jin, J. X.. Effect of berberine on the pharmacokinetics of substrates of CYP3A and P‐gp. Phytotherapy Research. 2009 doi:10.1002/ptr.2808